Skip to main content

Peer Review reports

From: Drug repurposing of pyrazolotriazine derivatives as potential anti-SARS-CoV-2 agents: in vitro and in silico studies

Original Submission
25 Sep 2023 Submitted Original manuscript
22 Oct 2023 Author responded Author comments - Amgad Albohy
Resubmission - Version 2
22 Oct 2023 Submitted Manuscript version 2
6 Nov 2023 Reviewed Reviewer Report
13 Nov 2023 Reviewed Reviewer Report
2 Feb 2024 Author responded Author comments - Amgad Albohy
Resubmission - Version 3
2 Feb 2024 Submitted Manuscript version 3
3 Feb 2024 Reviewed Reviewer Report
4 Apr 2024 Reviewed Reviewer Report
9 Apr 2024 Reviewed Reviewer Report
27 May 2024 Reviewed Reviewer Report - Rajimon KJ
23 Jun 2024 Author responded Author comments - Amgad Albohy
Resubmission - Version 4
23 Jun 2024 Submitted Manuscript version 4
24 Jun 2024 Reviewed Reviewer Report - Rajimon KJ
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
25 Jun 2024 Editorially accepted
16 Jul 2024 Article published 10.1186/s13065-024-01233-z

You can find further information about peer review here.

Back to article page